Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Motion to Dimiss Generic Zantac Lawsuits Granted on Preemption Grounds January 5, 2021 Irvin Jackson Add Your CommentsThe U.S. District judge presiding over all federal Zantac lawsuits issued a series of rulings late last week, granting motions to dismiss involving generic versions of the recalled heartburn drug and certain other claims brought on behalf of former users diagnosed with cancer.The rulings generally find that manufacturers of generic Zantac and other defendants, such as retailers, wholesalers, pharmacies and repackagers, can not be held liable for state law claims related to the cancer-causing chemicals that have been found to contaminate all medications containing the active ingredient ranitidine, finding that such claims are pre-empted by federal law. However, the ruling has no impact on claims involving use of brand-name Zantac products.Zantac (ranitidine) was one of the most widely known brand-name acid reflux medications before it was removed from the market last year, following the discovery that the drug is inherently unstable and produces high levels of the chemical byproduct N-Nitrosodimethylamine (NDMA), which is a known human carcinogen.Stay Up-to-Date AboutZantac LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments. "*" indicates required fieldsEmail* SIGN ME UPΔ Learn MoreStay Up-to-Date AboutZantac LawsuitsAboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits, and safety warnings that may impact your family, including any new Zantac lawsuit updates or legal developments."*" indicates required fieldsEmail* SIGN ME UPΔ Learn MoreThere are currently more than 500 product liability lawsuits filed in the federal court system, withย Zantac recall lawyersย investigating tens of thousands of additional claims for individuals diagnosed with breast cancer, testicular cancer, kidney cancer, bladder cancer, stomach cancer and other cancers that may have resulted from long-term exposure to NDMA in the medication.Given common questions of fact and law raised in complaints filed throughout the federal court system, the Zantac litigation was centralized last year before U.S. District Judge Robin L. Rosenberg in the Southern District of Florida, as part of an MDL, or multidistrict litigation.On December 31, Judge Rosenberg issued a series of orders granting a number of motions to dismiss filed by various defendants not involved in the actual development, creation or sale of the original brand name Zantac drug, finding that the state law claims involving generic versions of the drug are pre-empted by federal law. The orders granted motions to dismiss filed by generic manufacturersโ and repackagersโ (PDF), as well as retailers and pharmacy defendants (PDF).Federal preemption is a legal defense that prevents defendants from being held liable under state law claims for failing to take steps that would have been restricted by federal laws. Following a Supreme Court ruling several years ago, generic drug makers have often invoked the defense, arguing that they can not be held liable under state law for failing to warn, since FDA regulations require that generic medications carry the same warning label as the brand name drug they are copying.While the rulings do allow a number of defendants to escape any liability for their role in distributing and marketing the potentially cancer-causing drug, the litigation against makers of brand name prescription Zantac and over-the-counter versions remains. Most users allege in complaints that they received brand name versions of Zantac at various times, even if they also had generic ranitidine filled in some instances.In a related ruling issued the same day, Judge Rosenberg also rejected plaintiffsโ arguments of innovator liability (PDF), which attempted to argue that the brand name manufacturers should still be liable for injuries suffered by former users who only received generic versions of ranitidine.The theory of innovator liability holds that brand name manufacturers still owe a duty to use ordinary care in researching and developing the drug, and warning about safety risks associated with the treatment, regardless of whether the injured party ends up taking the brand name or generic version of the drug. However, Judge Rosenberg determined such claims are only permissible under Massachusetts and California laws.As part of the coordinated management of the remaining litigation over the link between Zantac and cancers diagnosed in recent years, it is expected Judge Rosenberg will establish a โbellwetherโ program, where small groups of representative cases will be prepared for a series of early trial dates unlikely to begin until at least 2022. It is likely a range of cases will be selected involving different types of cancer involved in large numbers of other claims, as well as cases involving exposure to different versions of Zantac, including name-brand prescription pills, over-the-counter and generic store-brands.While the outcome of these early trial dates will not be binding on other claims in the litigation, they may have a large impact on potential Zantac settlements the drug makers may negotiate for certain cancers, to avoid thousands of individual cases going before juries nationwide in coming years. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Drug Recall, Heartburn, Heartburn Drug, NDMA, ZantacMore Zantac Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 0 CommentsEmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026) Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026) Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 2 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
Olympus Wrongful Death Lawsuit Judge Calls for Quick Resolution (Posted: 3 days ago)A wrongful death lawsuit filed against Olympus Medical over an alleged medical scope infection could be ready for trial in about a year.MORE ABOUT: SCOPE INFECTION LAWSUITOlympus Scope Problems Lead to FDA Import Warning (10/27/2026)Fujifilm and Olympus Scope Infection Risks Highlight Growing Need for Advanced Disinfection Systems: Report (10/19/2026)Olympus Medical Device Warning Letter Follows FDA Inspections of Six Manufacturing Facilities (10/16/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: 4 days ago)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)